Cytarabine

BCL2 like 1 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35039904 Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia. 2022 Jan 18 1
2 33276759 Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death. 2020 Dec 4 1
3 30361682 Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML. 2018 Oct 25 1
4 23320492 Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line. 2013 Apr 2
5 19548087 Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cells. 2009 Sep 1
6 17311927 The cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), can deliver Bcl-XL as an extracellular fusion protein to protect cells from apoptosis and retain differentiation induction. 2007 Apr 13 1
7 16219908 Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2. 2006 Jan 2
8 11961058 Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L). 2002 May 3
9 10845427 The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. 2000 May 1
10 9502620 Bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells. 1998 Mar 1
11 9699642 "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. 1998 Aug 1 5
12 8822910 Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. 1996 Sep 15 1